PIM2 and NF-κβ gene expression in a sample of AML and ALL Egyptian patients and its relevance to response to treatment

Egyptian Journal of Medical Human Genetics

Table 4 Overall survival of AML and ALL patients in relation to NF κβ and PIM2 median expression level

	No.	No. of deaths	Cumulative survival at 3 months (%)	Median survival (months)	P value
AML patients group
NF κβ gene median expression
1.019^low$	15	1	93.3	---- %	0.047*
1.019^equal/high#	15	6	66.7	12.4
PIM2 gene median expression
1.389^low$	14	3	85.7	12.4	0.872
1.389^equal/high#	16	4	75.0	----
ALL patients group
NF κβ gene median expression
1.988^low$	14	3	78.6	----	0.228
1.988^equal/high#	14	6	60.0	----
PIM2 gene median expression
0.303^low$	14	3	64.3	----	0.872
0.303^equal/high#	14	4	71.4	----